510(k) · Cleared
ClearedProparaflu+Assay
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Prodesse, Inc. · OOU Parainfluenza Multiplex Nucleic Acid Assay
Cleared on Nov 20, 2009 as substantially equivalent to DEN070013 (Luminex Molecular Diagnostics, Inc., 2008) after a 221-day review. Its family tree reaches back 1 generation to 2008. 4 later devices descend from it.
- Decided
- Nov 20, 2009
- Review
- 221 days
- Class
- Class II
- Product code
- OOU
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to DEN070013 (2008). 4 later devices descend from it, 3 citing it directly.
- Root · 1 generation backDEN070013 ID-Tag Respiratory Viral PanelLuminex Molecular Diagnostics, Inc. · 2008
- This deviceK091053 Proparaflu+AssayProdesse, Inc. · 2009
- Descendant · cites it directly · 2 of its ownK132238 Proparaflu+ AssayGen-Probe Prodesse, Inc. · 2013
- Descendant · cites it directly · 1 of its ownK153223 ProParaFlu+ AssayHologic, Inc. · 2015
- Descendant · 2 generations on · 0 of its ownK172282 Panther Fusion Paraflu AssayHologic, Inc. · 2017
- Descendant · cites it directly · 0 of its ownK141927 Lyra Parainfluenza Virus AssayQuidel Corporation · 2014
Most influential descendants
Showing 4 of 4 · See all- K132238Proparaflu+ AssayGen-Probe Prodesse, Inc. · 2013 · cites it directly2descendants
- K153223ProParaFlu+ AssayHologic, Inc. · 2015 · cites it directly1descendant
- K172282Panther Fusion Paraflu AssayHologic, Inc. · 2017 · 2 generations on0descendants
- K141927Lyra Parainfluenza Virus AssayQuidel Corporation · 2014 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | DEN070013 | ID-Tag Respiratory Viral Panel | Luminex Molecular Diagnostics, Inc. | 2008 | — |
| 0 (this device) | K091053 | Proparaflu+Assay | Prodesse, Inc. | 2009 | — |
| +1 | K132238 | Proparaflu+ Assay | Gen-Probe Prodesse, Inc. | 2013 | — |
| +1 | K153223 | ProParaFlu+ Assay | Hologic, Inc. | 2015 | — |
| +2 | K172282 | Panther Fusion Paraflu Assay | Hologic, Inc. | 2017 | — |
| +1 | K141927 | Lyra Parainfluenza Virus Assay | Quidel Corporation | 2014 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 0 |
| 2017 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OOU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | DEN070013 | ID-Tag Respiratory Viral Panel Our reading of the summary gave K063765, which is not in FDA’s 510(k) list. The device the summary names is FDA’s De Novo DEN070013, ID-Tag Respiratory Viral Panel (Luminex Molecular Diagnostics, Inc.), granted Jan 3, 2008; older De Novo requests were first filed under a 510(k) number, so this links to the grant. | 2008 |
What descends from it? (4)
3 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All OOU devicesOOU Parainfluenza Multiplex Nucleic Acid Assay: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.
FDA decisions per year · OOU
1in 2017
2026 to Oct 25, outlined.
Median 510(k) review, days · OOU
Too few OOU 510(k)s in any year since 2007 to give a median.
Recalls per year · OOU
No recall names OOU since 2007.
Adverse event reports per year · OOU
No MAUDE report names OOU since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 1 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 1 | — | 0 | 0 |
| 2014 | 1 | — | 0 | 0 |
| 2015 | 1 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 1 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The ProParaflu+ Assay is a multiplex Real Time RT-PCR in vitro diagnostic test for the qualitative detection and discrimination of Parainfluenza 1 Virus, Parainfluenza 2 Virus and Parainfluenza 3 Virus (HPIV-1, HPIV-2 and HPIV-3) nucleic acids isolated and purified from nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of respiratory tract infections. This assay targets the conserved regions of the…
Read the full statement (158 words)
The ProParaflu+ Assay is a multiplex Real Time RT-PCR in vitro diagnostic test for the
qualitative detection and discrimination of Parainfluenza 1 Virus, Parainfluenza 2 Virus
and Parainfluenza 3 Virus (HPIV-1, HPIV-2 and HPIV-3) nucleic acids isolated and
purified from nasopharyngeal (NP) swab specimens obtained from individuals exhibiting
signs and symptoms of respiratory tract infections. This assay targets the conserved
regions of the Hemagglutinin-Neuraminidase (HN) gene of HPIV-1, HPIV-2 and HPIV-
3, respectively. The detection and discrimination of HPIV-1, HPIV-2 and HPIV-3
nucleic acids from symptomatic patients aid in the diagnosis of human respiratory tract
parainfluenza infections if used in conjunction with other clinical and laboratory findings.
This test is not intended to detect Parainfluenza 4a or Parainfluenza 4b Viruses.
Negative test results are presumptive and should be confirmed by cell culture. Negative
results do not preclude Parainfluenza 1,2 or 3 virus infections and should not be used as
the sole basis for treatment or other management decisions.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K091053 · printed Nov 4, 2026
Cite this page
510(k) Report. “K091053: Proparaflu+Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K091053
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026